The Natural History of Arrhythmogenic Cardiomyopathy with Pathogenic PKP2 Variants (PKP2-ACM): An observational cohort study
Clinical Trial Grant
Awarded By
Rocket Pharmaceuticals, Ltd
Start Date
April 24, 2025
End Date
April 30, 2029
Awarded By
Rocket Pharmaceuticals, Ltd
Start Date
April 24, 2025
End Date
April 30, 2029